NCT06406413

Brief Summary

The goal of this observational study is to learn about the micro-movements in patients with prolonged disorders of consciousness. The main questions it aims to answer are: Use the neuropsychological paradigm model to monitor micro-movements, assess the patient's remaining level of consciousness and accurately classify it; screen out patients with cognitive-motor dissociation to improve the prognosis of cognitive function; explore the remaining brain function of patients with chronic disorders of consciousness and promote relevant study of neural mechanisms. Participants will be subjected to consciousness assessment by CRS-r scale, and their micro-movement changes in response to various emotional stimuli will be captured, along with the collection of EEG and MRI data. Follow-up evaluations will be conducted using the CRS-R scale and GOS scale, with a follow-up period of 6 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started May 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
May 2024Dec 2026

Study Start

First participant enrolled

May 1, 2024

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 14, 2026

Status Verified

November 1, 2025

Enrollment Period

2.6 years

First QC Date

May 6, 2024

Last Update Submit

January 13, 2026

Conditions

Keywords

disorders of consciousnessconsciousness disordersmicro-movementconsciousnessMultidimensional paradigm stimulation

Outcome Measures

Primary Outcomes (1)

  • GOSE score

    GOS-E is an extended version of the Glasgow Outcome Scale (GOS), which was developed to provide a more detailed assessment of patient functionality and quality of life after experiencing such an injury. It has eight categories: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.

    six months

Secondary Outcomes (1)

  • CRS-R score

    six months

Study Arms (2)

DoC patients

patients with disorders of consciousness

Diagnostic Test: micro-movement; electroencephalogram; MRI

healthy controls

healthy participants matched by gender and age

Diagnostic Test: micro-movement; electroencephalogram; MRI

Interventions

micro-movement; electroencephalogram; MRI

DoC patientshealthy controls

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients are recruited from both general hospitals and rehabilitation hospitals.

You may qualify if:

  • Patients with consciousness disorders for more than 28 days following severe brain injury, assessed by the CRS-R scale to meet the criteria for VS or MCS;
  • Aged between 18 and 80 years;
  • Stable vital signs;
  • Voluntary participation of family members with signed informed consent;
  • Good cooperation, minimal facial and spontaneous activities, no use of antiepileptic or sedative drugs.

You may not qualify if:

  • Locked-in syndrome;
  • Contraindications for EEG examination;
  • Contraindications for MRI scanning, such as the presence of internal metallic implants;
  • Diseases and factors that may affect brain function assessment, such as metabolic disorders, poisoning, shock, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

First Affiliated Hospital,Zhejiang University

Hanzhou, Zhejiang, 310003, China

RECRUITING

MeSH Terms

Conditions

Consciousness Disorders

Interventions

ElectroencephalographyMagnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisTomographyDiagnostic Imaging

Central Study Contacts

Benyan Luo

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 9, 2024

Study Start

May 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 14, 2026

Record last verified: 2025-11

Locations